Publication:
Prostate cancer diagnosis-what to expect in the thai population?

dc.contributor.authorAkarasakul D.
dc.contributor.authorViriyasiripong S.
dc.date.accessioned2021-04-05T03:02:53Z
dc.date.available2021-04-05T03:02:53Z
dc.date.issued2019
dc.date.issuedBE2562
dc.description.abstractObjective: To study the prostate cancer detection rates upon transrectal ultrasound (TRUS) guided biopsy in relation to prostate-specific antigen (PSA) and digital rectal examination (DRE) included risk factors for prostate cancer diagnosis. Materials and Methods: 1,176 patients who underwent TRUS prostate biopsy between 2002 to 2008 were enrolled to the study. The prostate cancer detection rates with reference to PSA level and DRE finding were investigated. Logistic regression analysis was performed on age at biopsy, clinical symptoms, prostate-specific antigen (PSA), and DRE findings to identify significant risk factors. The correlation of DRE findings in combination with PSA value was also analyzed. Results: Referring to patients with normal DRE, the cancer detection rates were 10.8%, 12.9%, 21.3%, 42.6% and 77.8% in patients with PSA <4, 4 to 10, 10.01 to 20, 20.01 to 50 and >50 ng/ml, respectively. According to patients with abnormal DRE, the cancer detection rates were 15.0%, 20.7%, 41.2%, 60.5% and 84.8% in patients with PSA <4, 4 to 10, 10.01 to 20, 20.01 to 50 and >50 ng/ ml, respectively. Additionally, the age at biopsy, PSA level and DRE finding were the significant risk factors for prostate cancer diagnosis while clinical symptom was not. The data revealed that normal DRE finding in combination with PSA level was statistically significant when PSA level was above 20 ng/ml. Similarly, the abnormal DRE finding in combination with PSA level was statistically significant when PSA level was above 10 ng/ml. Conclusion: Thai men appeared to have lower prostate cancer detection rate when compared to the Western population. The age at biopsy, PSA level and DRE finding were the significant risk factors for prostate cancer. Besides, the combination of DRE and PSA level increased the accuracy and were the best tool for prostate cancer screening. © JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND| 2019.
dc.format.mimetypeapplication/pdf
dc.identifier.citationJournal of the Medical Association of Thailand. Vol 102, No.7 (2019), p.58-61
dc.identifier.issn1252208
dc.identifier.other2-s2.0-85070491879
dc.identifier.urihttps://hdl.handle.net/20.500.14740/5218
dc.rights.holderScopus
dc.subject.otherCiprofloxacin
dc.subject.otherProstate specific antigen
dc.subject.otherAdult
dc.subject.otherAge
dc.subject.otherAged
dc.subject.otherArticle
dc.subject.otherCancer diagnosis
dc.subject.otherCancer risk
dc.subject.otherControlled study
dc.subject.otherDigital rectal examination
dc.subject.otherHuman
dc.subject.otherHuman tissue
dc.subject.otherMajor clinical study
dc.subject.otherMale
dc.subject.otherMiddle aged
dc.subject.otherProstate biopsy
dc.subject.otherProstate cancer
dc.subject.otherRisk factor
dc.subject.otherThai (people)
dc.subject.otherTransrectal ultrasonography
dc.subject.otherVery elderly
dc.titleProstate cancer diagnosis-what to expect in the thai population?
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85070491879&partnerID=40&md5=89bcead85223aab30189d70275478b5d

Files